Innovent Biologics, Inc. (HKG:1801)
Hong Kong · Delayed Price · Currency is HKD 86.70
-1.40 (-1.59%)
Jul 31, 2026, 4:08 PM HKT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 150.94 billion as of July 31, 2026. Its market cap has decreased by -10.31% in one year.
Market Cap
150.94B
Enterprise Value
133.78B
Revenue
14.51B
Ranking
n/a
PE Ratio
165.77
Stock Price
86.70
ChartMarket Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 150.94B, an increase of 714.17%. That is a compound annual growth rate of 31.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 150.94B | 14.12% |
| Dec 31, 2025 | 132.27B | 120.60% |
| Dec 31, 2024 | 59.96B | -13.32% |
| Dec 29, 2023 | 69.17B | 34.57% |
| Dec 30, 2022 | 51.40B | -27.14% |
| Dec 31, 2021 | 70.55B | -38.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 275.49B |
| WuXi Biologics | 158.98B |
| Sichuan Kelun-Biotech Biopharmaceutical | 115.64B |
| Sino Biopharmaceutical | 89.56B |
| Akeso | 86.54B |
| RemeGen | 63.38B |
| Biocytogen Pharmaceuticals (Beijing) | 47.06B |
| 3SBio | 41.67B |